In8Bio INAB Income Statement (2020-2026)

NASDAQ INAB
$1.08 -0.06 (-5.26%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

In8Bio Quarterly Income Statement

Periods 25 quarters
Latest Jun 2026

In8Bio reported net income of -$4.78M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.45M0.33M0.63M0.63M0.82M0.82M0.83M1.02M1.07M1.00M1.47M1.55M1.56M1.78M2.71M4.08M4.59M4.37M19.47M19.47M
Operating items
Research & DevelopmentR&D
1.35M2.69M2.38M3.50M4.25M3.92M4.38M4.13M3.79M4.52M4.90M5.16M3.31M3.59M2.97M2.49M2.10M2.65M2.61M2.49M
Selling, General & AdministrativeSG&A
2.04M3.16M3.76M3.67M3.14M3.88M3.47M3.58M3.38M3.08M3.74M3.53M2.73M2.63M2.69M2.71M1.86M2.38M2.65M2.44M
Restructuring CostsRestructuring
1.07M
Operating ExpensesOpex
3.39M5.85M6.14M7.18M7.40M7.80M7.86M7.71M7.17M7.60M8.64M8.69M7.11M6.22M5.66M5.20M3.97M5.03M5.27M4.93M
Operating IncomeOp. Inc
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M-4.78M
EBIT
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M-4.78M
Non-operating items
Interest & Investment IncomeInt & Inv Inc
0.08M0.06M0.02M0.06M0.11M0.11M0.11M0.09M0.18M0.15M
Net income details
EBT
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.48M-8.57M-7.06M-6.10M-5.44M-4.99M-3.74M-4.85M-4.91M-4.63M
Profit After TaxPAT
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M-4.78M
Income from Continuing OperationsIncome (Continuing)
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.48M-8.57M-7.06M-6.10M-5.44M-4.99M-3.74M-4.85M-4.91M-4.63M
Consolidated Net IncomeConsol Net Inc.
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.48M-8.57M-7.06M-6.10M-5.44M-4.99M-3.74M-4.85M-4.91M-4.63M
Income towards Parent CompanyParent Net Inc
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.48M-8.57M-7.06M-6.10M-5.44M-4.99M-3.74M-4.85M-4.91M-4.63M
Net Income towards Common StockholdersNet Income
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.48M-8.57M-7.06M-6.10M-5.44M-4.99M-3.74M-4.85M-4.91M-4.63M
Additional items
EPS (Basic)
-7.61-17.60-9.81-11.44-10.25-11.16-9.13-8.13-6.82-7.63-5.88-5.70-4.48-3.42-1.96-1.21-0.82-1.11-0.25-0.24
EPS (Diluted)
-7.61-17.60-9.81-11.44-10.25-11.16-9.13-8.13-6.82-7.63-5.88-5.70-4.48-3.42-1.96-1.21-0.82-1.11-0.25-0.24
Shares Outstanding
0.45M0.33M0.63M0.63M0.72M0.70M0.82M0.95M1.05M1.00M1.44M1.50M1.58M1.78M2.78M4.12M4.54M4.37M19.47M19.47M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.45M0.33M0.63M0.63M0.72M0.70M0.82M0.95M1.05M1.00M1.44M1.50M1.58M1.78M2.78M4.12M4.54M4.37M19.47M19.47M
EBITDA
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M-4.78M